164 related articles for article (PubMed ID: 23241606)
1. Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma.
Repiská G; Sedláčková T; Szemes T; Celec P; Minárik G
Clin Chem Lab Med; 2013 Jun; 51(6):1185-9. PubMed ID: 23241606
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
[TBL] [Abstract][Full Text] [Related]
3. Selection of an optimal method for co-isolation of circulating DNA and miRNA from the plasma of pregnant women.
Sedlackova T; Repiska G; Minarik G
Clin Chem Lab Med; 2014 Nov; 52(11):1543-8. PubMed ID: 24815052
[TBL] [Abstract][Full Text] [Related]
4. Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit.
Clausen FB; Krog GR; Rieneck K; Dziegiel MH
Prenat Diagn; 2007 Jan; 27(1):6-10. PubMed ID: 17154236
[TBL] [Abstract][Full Text] [Related]
5. Fetal DNA: strategies for optimal recovery.
Legler TJ; Heermann KH; Liu Z; Soussan AA; van der Schoot CE
Methods Mol Biol; 2008; 444():209-18. PubMed ID: 18425483
[TBL] [Abstract][Full Text] [Related]
6. Isolation of cell-free DNA from maternal plasma using manual and automated systems.
Huang DJ; Mergenthaler-Gatfield S; Hahn S; Holzgreve W; Zhong XY
Methods Mol Biol; 2008; 444():203-8. PubMed ID: 18425482
[TBL] [Abstract][Full Text] [Related]
7. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.
Devonshire AS; Whale AS; Gutteridge A; Jones G; Cowen S; Foy CA; Huggett JF
Anal Bioanal Chem; 2014 Oct; 406(26):6499-512. PubMed ID: 24853859
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma.
Akbariqomi M; Heidari R; Gargari SS; Omrani MD; Rigi G; Sanikhani NS; Kooshki H; Mahmoudian F; Mazlomi MA; Tavoosidana G
J Assist Reprod Genet; 2019 May; 36(5):1029-1038. PubMed ID: 30820784
[TBL] [Abstract][Full Text] [Related]
9. Isolation and analysis of cell-free fetal DNA from maternal peripheral blood in Chinese women.
Yang WC; Zhu L; Qiu YM; Zhou BX; Cheng JL; Wei CL; Chen HC; Li LY; Fu XD; Fu JJ
Genet Mol Res; 2015 Dec; 14(4):18078-89. PubMed ID: 26782455
[TBL] [Abstract][Full Text] [Related]
10. Workshop report on the extraction of foetal DNA from maternal plasma.
Legler TJ; Liu Z; Mavrou A; Finning K; Hromadnikova I; Galbiati S; Meaney C; Hultén MA; Crea F; Olsson ML; Maddocks DG; Huang D; Fisher SA; Sprenger-Haussels M; Soussan AA; van der Schoot CE
Prenat Diagn; 2007 Sep; 27(9):824-9. PubMed ID: 17604339
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma.
Lim JH; Lee BY; Kim JW; Han YJ; Chung JH; Kim MH; Kwak DW; Park SY; Choi HB; Ryu HM
J Assist Reprod Genet; 2018 Apr; 35(4):637-641. PubMed ID: 29423788
[TBL] [Abstract][Full Text] [Related]
12. Identifying the minimum concentrations of cell-free fetal DNA in maternal blood required for bovine fetal sexing using PCR.
Singh N; Fernando C; Hill JE; Singh J; Campbell J; Dadarwal D
Theriogenology; 2022 Oct; 191():192-199. PubMed ID: 35998402
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
14. Specific magnetic bead-based capture of free fetal DNA from maternal plasma.
Legler TJ; Liu Z; Heermann KH; Hempel M; Gutensohn K; Kiesewetter H; Pruss A
Transfus Apher Sci; 2009 Jun; 40(3):153-7. PubMed ID: 19364676
[TBL] [Abstract][Full Text] [Related]
15. Quantification of circulatory fetal DNA in the plasma of pregnant women.
Zimmermann BG; Maddocks DG; Avent ND
Methods Mol Biol; 2008; 444():219-29. PubMed ID: 18425484
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
[TBL] [Abstract][Full Text] [Related]
18. The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada.
Okun N; Teitelbaum M; Huang T; Dewa CS; Hoch JS
Prenat Diagn; 2014 Apr; 34(4):350-6. PubMed ID: 24395030
[TBL] [Abstract][Full Text] [Related]
19. Do we need to worry about contamination by circulating fetal DNA?
Wu H; Huang G; Romay-Penabad Z; Pierangeli S; Dong J
Clin Chem Lab Med; 2014 May; 52(5):e75-7. PubMed ID: 24353144
[No Abstract] [Full Text] [Related]
20. Comparison of 4 commercial kits for the extraction of circulating DNA from plasma.
Warton K; Graham LJ; Yuwono N; Samimi G
Cancer Genet; 2018 Dec; 228-229():143-150. PubMed ID: 29567030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
